840062 | 16:0-22:6 PS
1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phospho-L-serine (sodium salt)
Info
16:0-22:6 PS
1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phospho-L-serine (sodium salt)
Data
Yes
Yes
C44H73NO10PNa
C 63.67%, H 8.86%, N 1.69%, Na 2.77%, O 19.28%, P 3.73%
>99%
3 Months
-20°C
CAS Number
474943-17-4
CAS Registry Number is a Registered Trademark of the American Chemical Society
CAS Registry Number is a Registered Trademark of the American Chemical Society
830.015
829.487
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-L-serine (sodium salt)
PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
References
Hescot S, Amazit L, Lhomme M, Travers S, DuBow A, Battini S, Boulate G, Namer IJ, Lombes A, Kontush A, Imperiale A, Baudin E, Lombes M. Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approaches. Oncotarget. 2017 Jul 4;8(66):109924-109940. doi: 10.18632/oncotarget.18968. PMID: 29299119; PMCID: PMC5746354.
PubMed ID: 29299119
Certificates of Analysis
- Certificate of Analysis (Lot No. 840062C-25MG-A-020 and 5517CJA020)
- Certificate of Analysis (Lot No. 840062C-25MG-B-020 and 5517CJB020)
- Certificate of Analysis (Lot No. 840062C-25MG-C-020 and 5517CJC020)
- Certificate of Analysis (Lot No. 840062C-25MG-E-020 and 5517CJE020)
- Certificate of Analysis (Lot No. 840062C-25MG-F-020 and 5517CJF020)
- Certificate of Analysis (Lot No. 840062C-25MG-G-020 and 5517CJG020)